OKYO Pharma Limited (NASDAQ: OKYO)
In compliance with section 17(b) of the Securities Act, we are disclosing that OKYO Pharma Limited (NASDAQ: OKYO) is a client of TraDigital Marketing Group, Inc. OKYO Pharma Limited has an agreement in place, dated August 25, 2023 – August 28, 2023 to compensate TraDigital Marketing Group, Inc. a cash retainer of one hundred seventy-five thousand dollars ($175,000) for publicly disseminating information about OKYO Pharma Limited via website, email, and SMS.
In compliance with section 17(b) of the Securities Act, we are disclosing that OKYO Pharma Limited (NASDAQ: OKYO) is a client of TraDigital Marketing Group, Inc. OKYO Pharma Limited has an agreement in place, dated October 2, 2023 – October 5, 2023 to compensate TraDigital Marketing Group, Inc. a cash retainer of two hundred fifty thousand dollars ($250,000) for publicly disseminating information about OKYO Pharma Limited via website, email, and SMS.
In compliance with section 17(b) of the Securities Act, we are disclosing that OKYO Pharma Limited (NASDAQ: OKYO) is a client of TraDigital Marketing Group, Inc. OKYO Pharma Limited has a 3-day agreement in place, dated March 20, 2024 – March 22, 2024 to compensate TraDigital Marketing Group, Inc. a cash retainer of thirty-five thousand dollars ($35,000) for publicly disseminating information about OKYO Pharma Limited via website, email, and SMS.
Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.